Aberdeen Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.1M Hold
337,839
0.05% 306
2026
Q1
$32.7M Hold
337,839
0.05% 294
2025
Q4
$35.9M Sell
337,839
-13,992
-4% -$1.62M 0.06% 277
2025
Q3
$44.3M Buy
351,831
+922
+0.3% +$110K 0.07% 234
2025
Q2
$43M Buy
350,909
+1,184
+0.3% +$135K 0.07% 231
2025
Q1
$35.4M Buy
349,725
+156,628
+81% +$15.3M 0.07% 244
2024
Q4
$17.8M Buy
+193,097
New +$19M 0.03% 394

Other funds holding EHC

Aberdeen Group's EHC Position: Q2 2026 in Review

Aberdeen Group held its Encompass Health (EHC) position steady in Q2 2026 at 337,839 shares worth $34.1M. The position accounts for 0.05% of the portfolio, ranked #306.

Aberdeen Group first reported a position in EHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $44.3M in Q3 2025. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Aberdeen Group held 337,839 shares of Encompass Health worth $34.1M as of Q2 2026.
  • Aberdeen Group left its Encompass Health share count unchanged in Q2 2026.
  • Encompass Health made up 0.05% of Aberdeen Group's portfolio in Q2 2026, its #306 holding.
  • Aberdeen Group first reported a position in Encompass Health in Q4 2024 and has held it in 7 quarters since.
  • Aberdeen Group's Encompass Health position peaked at $44.3M in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.